Tania Bubela

Tania Bubela

Professor, School of Public Health, University of Alberta (Edmonton, AB)

March 9, 2017

Dr. Tania Bubela is a Professor of health policy and management in the School of Public Health at the University of Alberta. She is an Adjunct Professor in Marketing, Business Economics and Law at the Alberta School of Business. Dr. Bubela sits on the Stem Cell Oversight Committee and serves as Scientific Officer for the Foundation Scheme at the Canadian Institutes of Health Research. She has been a Principal Investigator with the Canadian Stem Cell Network since 2008.

Dr. Bubela holds a JD (distinction) from the University of Alberta, a PhD from the University of Sydney, and a B.Sc. (honours) from the Australian National University. Following her JD, she clerked for the Honourable Louise Arbour at the Supreme Court of Canada and was called to the bar (Law Society of Alberta) in 2005.

Dr. Bubela’s research focuses on three main areas in health and biotechnology law and policy: knowledge translation in health, biotechnology and new technologies in biomedicine; impacts of commercialization/open science and intellectual property policies in biomedical research; and the use of commons theory to analyze the institutional development of bioresource and data repositories for biomedical research and precision medicine. She currently holds over $10 million in research grants as principal investigator/co-lead from CIHR, Alberta Innovates-Health Solutions, Genome Canada, and the Networks of Centres of Excellence. She has over 100 academic publications, including in high-impact scientific journals such as Nature, Nature Biotechnology, PLoS Biology, Science Translational Medicine, and Cell Stem Cell.

In 2015-2016, Dr. Bubela was a Vice President Research Fellow reviewing the policies, practices and procedures of the University of Alberta’s Research Services Office, and in 2014, she received a McCalla Professorship from the University of Alberta. She served as Associate Dean for Research in the School of Public Health from 2014 to 2016.

Role: Steering Committee Member
Report: Building on Canada's Strengths in Regenerative Medicine (March 2017)